• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高脂血症与过氧化物酶体增殖物激活受体(PPAR)——CLOCK:BMAL1对PPARα基因的调控]

[Hyperlipidemia and peroxisome proliferator-activated receptor (PPAR)--regulation of the PPARalpha gene by CLOCK: BMAL1].

作者信息

Inoue Ikuo

机构信息

Fourth Department of Medicine, Saitama Medical School.

出版信息

Nihon Rinsho. 2005 Apr;63(4):643-56.

PMID:15828232
Abstract

The main pathological findings in atherosclerosis include abnormal reactions of neutrophils, lymphocytes and monocytes/macrophages, vascular smooth muscle cells and vascular endothelial cells, and the accumulation of cholesterol ester in the arterial wall. Therefore, investigating the effects of these abnormal reactions on the arterial wall may improve understanding of the mechanisms underlying atherosclerosis. Three types of peroxisome proliferator-activated receptors (PPARs): PPARalpha, PPARbeta/delta, and PPARgamma are expressed in endothelial cells. In endothelial cells, the ligands/activators for PPARalpha and PPARgamma increase Cu2+, Zn2+ -superoxide dismutase. In addition, the phorbol myristate acetate (PMA)-stimulated 22 kDa-subunit (p22phox) protein levels and 47 kDa-subunit (p47phox) protein levels in NADPH (superoxide generating enzyme nicotinamide adenine dinucleotide phosphate (reduced form)) oxidase were decreased by treatment with PPARalpha and PPARgamma ligands/activators. Recently, we showed that the CLOCK: BMAL1 heterodimer regulates the PPARalpha gene via promoter of PPARalpha. Moreover, we report a patient with severe hypertriglyceridemia associated with anemia and hypoalbuminemia, in which the former may have caused the latter two conditions. This is the first reported case of abrupt onset of severe hypertriglyceridemia resulting in suppression of bone marrow and liver function. Here, based on recent studies including our own, we describe the relationships between risk factors for atherosclerosis, especially hyperlipidemia and PPARs and the molecular mechanisms that govern lipid metabolism in the arteries.

摘要

动脉粥样硬化的主要病理表现包括中性粒细胞、淋巴细胞和单核细胞/巨噬细胞、血管平滑肌细胞及血管内皮细胞的异常反应,以及胆固醇酯在动脉壁的蓄积。因此,研究这些异常反应对动脉壁的影响可能有助于增进对动脉粥样硬化潜在机制的理解。过氧化物酶体增殖物激活受体(PPAR)有三种类型:PPARα、PPARβ/δ和PPARγ,它们在内皮细胞中表达。在内皮细胞中,PPARα和PPARγ的配体/激活剂可增加铜离子、锌离子超氧化物歧化酶。此外,用PPARα和PPARγ配体/激活剂处理后,佛波酯(PMA)刺激的NADPH(超氧化物生成酶烟酰胺腺嘌呤二核苷酸磷酸(还原型))氧化酶中的22 kDa亚基(p22phox)蛋白水平和47 kDa亚基(p47phox)蛋白水平降低。最近,我们发现CLOCK:BMAL1异二聚体通过PPARα启动子调节PPARα基因。此外,我们报告了一例患有严重高甘油三酯血症并伴有贫血和低白蛋白血症的患者,前者可能导致了后两种情况。这是首次报道的严重高甘油三酯血症突然发作导致骨髓和肝功能受抑制的病例。在此,基于包括我们自己的研究在内的近期研究,我们描述动脉粥样硬化危险因素,尤其是高脂血症与PPARs之间的关系以及动脉中脂质代谢的分子机制。

相似文献

1
[Hyperlipidemia and peroxisome proliferator-activated receptor (PPAR)--regulation of the PPARalpha gene by CLOCK: BMAL1].[高脂血症与过氧化物酶体增殖物激活受体(PPAR)——CLOCK:BMAL1对PPARα基因的调控]
Nihon Rinsho. 2005 Apr;63(4):643-56.
2
The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.过氧化物酶体增殖物激活受体α(PPARα)和PPARγ的配体/激活剂可增加原代内皮细胞中铜锌超氧化物歧化酶的含量,并降低p22phox的信使核糖核酸表达。
Metabolism. 2001 Jan;50(1):3-11. doi: 10.1053/meta.2001.19415.
3
Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.过氧化物酶体增殖物激活受体(PPAR)α和PPARβ/δ而非PPARγ,调节参与心脏脂质代谢的基因的表达。
Circ Res. 2003 Mar 21;92(5):518-24. doi: 10.1161/01.RES.0000060700.55247.7C. Epub 2003 Feb 6.
4
Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.过氧化物酶体增殖物激活受体与动脉粥样硬化形成:血管细胞中基因表达的调节因子
Circ Res. 2004 May 14;94(9):1168-78. doi: 10.1161/01.RES.0000127122.22685.0A.
5
Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.过氧化物酶体增殖物激活受体和法尼醇X受体配体在体外对人皮脂腺器官培养物中的皮脂腺分化有不同的调节作用。
Br J Dermatol. 2004 Oct;151(4):766-75. doi: 10.1111/j.1365-2133.2004.06171.x.
6
Peroxisome proliferator-activated receptors and inflammation.过氧化物酶体增殖物激活受体与炎症
Pharmacol Ther. 2006 Jun;110(3):371-85. doi: 10.1016/j.pharmthera.2005.08.007. Epub 2005 Sep 15.
7
CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response element.CLOCK/BMAL1通过过氧化物酶体增殖物激活受体(PPAR)反应元件的反式激活参与脂质代谢。
J Atheroscler Thromb. 2005;12(3):169-74. doi: 10.5551/jat.12.169.
8
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.药物洞察:过氧化物酶体增殖物激活受体激动剂的作用机制及治疗应用
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397.
9
Obesity alters circadian expressions of molecular clock genes in the brainstem.肥胖会改变脑干中分子时钟基因的昼夜节律表达。
Brain Res. 2009 Mar 31;1263:58-68. doi: 10.1016/j.brainres.2008.12.071. Epub 2009 Jan 15.
10
Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.配体激活的过氧化物酶体增殖物激活受体(PPAR)α和PPARγ对STAT5b转录活性的下调作用。
Mol Pharmacol. 2003 Aug;64(2):355-64. doi: 10.1124/mol.64.2.355.